US Edition
Enforcement Marches on: OPDP Issues Third Untitled Letter of 2025 Amid Staffing Shake-Ups
Summary by WisLawNOW
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Enforcement Marches on: OPDP Issues Third Untitled Letter of 2025 Amid Staffing Shake-Ups
Despite recent reductions-in-force (“RIFs”) at the Food and Drug Administration (“FDA” or “Agency”), the Agency’s Office of Prescription Drug Promotion (“OPDP”) has signaled that enforcement remains a priority. On April 28, 2025, OPDP issued its third Untitled Letter of the year — notably, the first following the April 1 RIFs, which impacted OPDP staffing. As of now, OPDP appears to be on pace to exceed the number of Untitled Letters issued in 2…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
